| Health / Medical Topics |
Momelotinib
An orally bioavailable small-molecule inhibitor of Janus kinases 1 and 2 (JAK1/2) with potential antineoplastic activity. JAK1/2 inhibitor CYT387 competes with JAK1/2 for ATP binding, which may result in inhibition of JAK1/2 activation, inhibition of the JAK-STAT signaling pathway, and so the induction of apoptosis and a reduction of tumor cell proliferation in JAK1/2-expressing tumor cells. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity and is often dysregulated in a variety of tumor cell types. (NCI Thesaurus)
YOU MAY ALSO LIKE
An element with atomic symbol Mo, atomic number 42, and atomic weight 95.94.
Issue associated with a solid device or device components being transformed into a molten or liquid state.
A replication-defective murine sarcoma virus isolated from a rhabdomyosarcoma by Moloney in 1966.
The TB strain of the Moloney Murine Leukemia Virus that arises during the propagation of the S37 mouse sarcoma model.
A murine virus arising during the propagation of S37 mouse sarcoma, and causing lymphoid leukemia in mice. It also infects rats and…
A species of enveloped and brick-shaped viruses in the Poxviridae family and Molluscipoxvirus genus. The genome is composed of non-segmented, linear double-stranded…
